On the morning of April 19, the key project introduced by the Economic Development Bureau of Hengqin Guangdong Macao deep cooperation zone (hereinafter referred to as the cooperation zone) - Federal Biotechnology (Hengqin) Co., Ltd. (hereinafter referred to as federal Biotechnology) opened in the Guangdong Macao cooperative traditional Chinese Medicine Technology Industrial Park.
United Laboratories is a wholly-owned subsidiary of United Laboratories International Holding Co., Ltd. (hereinafter referred to as United Laboratories), a pharmaceutical enterprise. It is also the biomedical R & D headquarters of United Laboratories. At present, federal biology has leased about 2000 square meters (including laboratories) in the Guangdong Macao cooperative traditional Chinese medicine science and Technology Industrial Park, and the R & D investment has exceeded 200 million yuan.
Cai Haishan, chairman of the board of directors of UL, said that relying on high-end sharing technologies such as the Internet, Internet of things and big data in the park, with the strong power of listed insulin products and professional R & D team, UL will achieve more innovative achievements in the future.
The overall plan for the construction of Hengqin Guangdong Macao deep cooperation zone proposes to vigorously develop the biomedical industry.
According to the relevant person in charge of the Economic Development Bureau of the cooperation zone, Hengqin has issued the special measures for Hengqin new area to support the development of Guangdong Macao cooperative traditional Chinese medicine science and Technology Industrial Park (hereinafter referred to as the “special measures”), which covers subsidies such as equipment purchase, the entry of national medical masters and famous traditional Chinese medicine teams, and the use of pharmaceutical R & D Contract outsourcing service platform.
According to this measure, Guangdong Macao traditional Chinese medicine science and Technology Industrial Park Development Co., Ltd. will build an open public service platform for enterprises in the park and receive a one-time equipment purchase subsidy of no more than 10 million yuan.
At the same time, the Industrial Park introduces social capital and sets up a pharmaceutical R & D Contract outsourcing service platform in the park in a commercial mode to provide public experimental equipment, early R & D support, pilot scale-up and process optimization, small batch production and other services for enterprises in the park. Enterprises in the park that use the platform can be given up to 50% of the actual cost of using the platform, and a single enterprise shall not exceed 2 million yuan.
The “special measures” also proposed that the industrial park development company and its wholly-owned subsidiaries can apply for special fund support of up to 5 million yuan and 2 million yuan respectively if they meet the conditions for the team of national medical masters recognized by the national competent department and the team of famous traditional Chinese medicine recognized by the competent department above the provincial level
Under the “drip irrigation” of various industrial support policies, medical and health enterprises have settled in Hengqin. At present, more than 4000 medical and health enterprises have been registered in the cooperation zone, covering new drug research and development, biomedicine, medical services, drug trade, great health and other fields.
The Guangdong Macao cooperative traditional Chinese medicine science and Technology Industrial Park where federal biology is located is the first landing project under the Guangdong Macao cooperation framework agreement. It is an important carrier for Macao to promote the industrialization and internationalization of traditional Chinese medicine. It is also the “main position” for the development of medical and health industries in Qinhuangdao and Macao. At present, there are 220 registered enterprises in the industrial park, involving traditional Chinese medicine, cosmetics, health products, medical devices, biomedicine and medical services, and the industrial agglomeration effect is beginning to show.
In the near future, the cooperation zone will also promote the introduction of policies to support the development of biomedicine and large-scale health industry, further expand the links of supporting the research and development of innovative drugs and improved new drugs, traditional Chinese medicine compound preparations and traditional Chinese medicine with the same name and formula, encourage the research and development of products with traditional Chinese medicine characteristics such as health food and cosmetics of traditional Chinese medicine (natural drugs), and promote the promotion of industrial cooperation and industrial innovation and transformation between Guangdong and Macao.
In the future, federal biology will continue to invest more than 1.5 billion yuan in R & D in the cooperation zone. It is expected that nearly 100 people will work in Hengqin by the end of this year.